Covid-19 screening solution for Humans to trace and isolate rapidly

Our rapid Covid-19 diagnostic test for Human use

BEC-SARS-CoV-2 for humans is a Covid-19 virological diagnostic test jointly developed with our company, Institut Pasteur, Bertin and Enalees.

Its design allows the detection of Covid-19 in humans on-site, within 20 minutes (from sampling to results), with one internal control.

The analytical part of the human diagnostic test must be performed using our device C4Reader T8 (light, compact and with a working autonomy of 24 hours).

The test has been positively evaluated by the CIBU (the Laboratory for Urgent Response to Biological Threats of the Institut Pasteur). It is also approved by the French National Reference Center for Respiratory Infections Virus, which reported a “Good analytical performance and equivalent to the RT PCR reference method – from already extracted nucleic acids“.

The clinical trial of this human diagnostic test is in progress.

 

Press releases

September 16, 2020

C4Diagnostics, Bertin Technologies, and Enalees announce the launch of their clinical trial of BEC-SARS-CoV-2 for humans, a rapid point-of-care Covid-19 diagnostic test

PARTNERS

Recevez notre étude de cas

Recevez notre étude de cas

C4Diagnostics a mis au point un protocole de prélèvement et de détection du SARS-CoV-2 pour les eaux usées, testé et utilisé par les Marins-Pompiers dans les EHPAD des Bouches-du-Rhône. 

Découvrez les résultats de notre étude complète sur les eaux usées.

Vous allez recevoir le document par mail très bientôt. Si vous ne le recevez pas, vérifiez votre courrier indésirable.